NCBI PubMed Central
open access
Outer nuclear layer thinning as an in vivo biomarker for discriminating probable FTLD-tau from probable FTLD-TDP with PET-supported subtyping.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Predictive imaging biomarkers on whole-body diffusion-weighted MRI (WB-DWMRI) and [(68)Ga]GaPSMA-PET/CT for [(177)Lu]LuPSMA therapy in metastatic prostate cancer (mCRPC).#340405
- Tau368 improves p-tau diagnostic accuracy for FTLD-tau from FTLD-TDP#317281
- Exploring the origins of frequent tau-PET signal in vermal and adjacent regions#164145
- Phase III Clinical Trial to Evaluate INR101 Injection for PET/CT Imaging in Patients With Prostate Cancer.#845808
- Direct interaction between TDP-43 and Tau promotes their co-condensation, while suppressing Tau fibril formation and seeding#461583
Record · ID 670946
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive